Airway diseases
Oral presentation
Notable Studies in Asthma
Methods :
Cell and molecular biology, Imaging, Physiology, General respiratory patient care
08:30
Late Breaking Abstract - Airway sensory innervation is increased in chronic cough
E. Blum(Portland, United States)
COI
1
08:45
Late Breaking Abstract - Long-term safety & durability of mepolizumab in life-threatening/seriously debilitating severe eosinophilic asthma (SEA): COSMEX
F. Albers(Chapel Hill, United States)
COI
2
09:00
Late Breaking Abstract - Long-term safety and efficacy of benralizumab in severe, uncontrolled asthma: first results of BORA, a randomized, Phase III extension study
W. Busse(Madison, United States)
COI
3
09:15
Late Breaking Abstract - Patients with severe eosinophilic asthma benefit from the treatment with Anti-IL-5 Reslizumab – a real life study from Austria
K. Marth(Wien, Austria)
COI
4
09:30
Late Breaking Abstract - Transcriptomic Profiling of Severe Asthma using Artificial Intelligence techniques
M. Hachim(Sharjah, United Arab Emirates)
COI
5
09:45
Late Breaking Abstract - Longitudinal analysis of variation in clinical features from the U-BIOPRED severe asthma cohort
D. Shaw(Leicester, United Kingdom)
COI
6
10:00
Late Breaking Abstract - Gender and asthma: Gender-dependent effects of obesity on allergic pulmonary inflammation
R. Lacerda(Campinas, Brazil)
COI
7
10:15
Late Breaking Abstract - Which treatable traits matter? Prevalence of treatable traits and risk of exacerbation in a random population sample with asthma
J. Fingleton(Wellington, New Zealand)
COI
8
. . .
